Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus

Human Genetics

Volumn 97, Issue 3, 1996, Pages 369-374

  Blakemore, Alexandra I F ^a,c   Cox, Angela ^a   Gonzalez, Ana Maria ^a   Maskill, Joanna K ^a,c   Hughes, Marianne E ^b   Wilson, R Malcolm ^b   Ward, John D ^b   Duff, Gordon W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC MARKER; HUMAN; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; DIABETIC NEPHROPATHIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; RECEPTORS, INTERLEUKIN-1;

EID: 0030062817     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02185776     Document Type: Article

References (42)

1. Barbosa J, Saner B (1984) Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetoloaia 27: 487-492
2. Bergholdt R, Pociot F, Ye K, Dinarello CA, Nerup J (1994) Genetic-variation of the interleukin-1 receptor locus - a new marker for iddm. Diabetologia 37:A6
3. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism as a severity factor in SLE. Arthritis Rheum 37: 1380-1385
4. Chandra T, Lakshmi CN, Padma T, Vidyavathi M, Satapathy M (1991) Haptoglobin phenotypes in diabetes mellitus and diabetic retinopathy. Hum Hered 41:347-350
5. Christy M, Anderson AR, Nerup J, Platz P, Ryder L, Thomsen L, Morling M, Svejgaard A (1981) HLA-DR typing in longstanding IDDM with and without nephropathy - evidence for heterogeneity? Diabetologia 21:259
6. Clay FE, Tarlow JK, Blakemore AIF, Harrington CI, Lewis F, Cork MJ, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 94:407-410
7. Cominelli F, Nast CC, Duchini A, Lee M (1992) Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65-71
8. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornelius F, Barnett AH, Bain SL, Todd JA (1995) Linkage disequilibrium mapping of a type-1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 9: 80-85.
9. Cork MJ, Tarlow JK, Blakemore AIF, McDonagh AJG, Messenger AG, Bleehan SS, Duff GW (1993) Genetics of IL-1 receptor antagonist in inflammatory skin diseases (abstract). J Invest Dermatol 100: 522
10. Cruickshanks KJ, Vadheim CM, Moss SE, Roth M-P, Riley MJ, Maclaren NK, Langfield D, Sparkes RS, Klein R, Rotter JI (1992) Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 years of age. Diabetes 41:879-885
11. Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99: 303-310
12. Dinarello CA (1991a) Interleukin-1. In: Thomson A (ed) The cytokine handbook, 1st edn. Academic Press, London, pp 47-82
13. Dinarello CA (1991b) Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652
14. Duff GW (1989) Protein regulatory factors in non-malignant diseases. Lancet 24: 1432-1435
15. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407
16. Freedman BI, Heise ER, Canzanello VJ (1992) Diabetic neuropathy and HLA-DR3/4. Ann Intern Med 117:445
17. Groop LC, Teir H, Koskimies S, Groop P, Matikainen E, Verkkala E, Scheinin T, Kontiainen S, Teppo A, Tolppanen E, Tallgren LG (1986) Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes 35: 1397-1403
18. Hawrami K, Mohan R, Mohan V, Hitman GA (1991) A genetic study of retinopathy in south Indian type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:441-444
19. Hendriksen PH, Oey PL, Wieneke GH, Bravenboer B, Banga JD (1992) Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:690-695
20. Ikeda M, Ikeda U, Ohkawa F, Shimada K, Kano S (1994) Nitric oxide synthesis in rat mesangial cells induced by cytokines (abstract). Cytokine 6:602-607
21. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014
22. Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello CA, Nerup J (1994) Monokine antagonism is reduced in patients with IDDM. Diabetes 43: 1242-1247
23. Mansfield JC, Holden H, Tarlow JK, McDowell TL, Wilson AG, Di Giovine FS, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106: 637-642
24. McCann VJ, McCluskev J, Kay PH, Zilko PJ, Christiansen FT, Dawkins RL (1983) HLA and complement genetic markers in diabetic retinopathy. Diabetologia 24: 221
25. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 38: 221-228
26. Mijovic C, Fletcher J, Bradwell AR, Harvey T, Barnett AH (1985) Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications. Br Med J 291:9-10
27. Mijovic C, Fletcher JA, Bradwell AR, Barnett AH (1986) Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition. Br Med J 292:433-435
28. Nicklin MHJ, Weith A, Duff GW (1994) A physical map of the region encompassing the human interleukin-1α, β and the interleukin-1 receptor antagonist genes. Genomics 19: 382-384
29. Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100:585-658
30. Payton CD, Boulton-Jones JM (1989) Genetic factors in the development of nephropathy in diabetic Lewis and DA rats. Clin Sci 77:521-527
31. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443
32. Ritz E, Hasslacher C, Tschope W (1990) Diabetic nephropathy - are there differences between type I and type II? Miner Electrolyte Metab 16:69-72
33. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165
34. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H (1991) Human and rat mesangial receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939
35. Tam FWK, Smith J, Cashman S, Wang Y, Thompson EM, Rees A (1992) Co-ordinated expression of glomerular interleukin-1 beta and its receptor antagonist (IL-1ra) mRNA and infiltration of leukocytes during induction of nephrotoxic nephritis in rat (abstract). J Am Soc Nephrol 3:617
36. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duft GW (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403-404
37. Tarlow JK, Clay FE, Cork MJ, Blakemore AIF, McDonagh AJG, Messenger AG, Duff GW (1994) Alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103:387-390
38. Vlassara H, Brownlee M, Cerami A (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82:5588-5592
39. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 240: 1546-1548
40. Walker JD, Tariq T, Viberti G (1990) Sodium-lithium counter-transport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br Med J 301:635-638
41. Watts GF, Taub N, Gant V, Wison I, Shaw KM (1992) The immunogenetics of early nephropathy in insulin-dependent diabetes mellitus: association between the HLA-A2 antigen and albuminuria. Q J Med 83:461-471
42. Yue DK, McLennan SV, Turtle JR (1992) Pathogenesis of diabetic microangiopathy: the roles of endothelial cell and basement membrane abnormalities. Diabet Med 9:218-220